Approval · Notice of Compliance 24150 · 2020
TEVA-FINASTERIDE: Notice of Compliance 24150
Issued September 1, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24150
- Date
- September 1, 2020
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monogeraph
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-FINASTERIDE | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB